Serine protease inhibitor Kazal type 1 promotes epithelial–mesenchymal transition through EGFR signaling pathway in prostate cancer. Issue 7 (12th March 2014)
- Record Type:
- Journal Article
- Title:
- Serine protease inhibitor Kazal type 1 promotes epithelial–mesenchymal transition through EGFR signaling pathway in prostate cancer. Issue 7 (12th March 2014)
- Main Title:
- Serine protease inhibitor Kazal type 1 promotes epithelial–mesenchymal transition through EGFR signaling pathway in prostate cancer
- Authors:
- Wang, Chunni
Wang, Lin
Su, Bo
Lu, Ning
Song, Jingjing
Yang, Xiaoqing
Fu, Weiwei
Tan, Weiwei
Han, Bo - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="pros22787-sec-0001" sec-type="section"> <title>BACKGROUND</title> <p>Overexpression of serine protease inhibitor Kazal type 1 (SPINK1) defines an aggressive molecular subtype of ETS fusion‐negative prostate cancer (PCa) patients in western countries. However, how SPINK1 contributes to PCa invasion and metastasis is largely unknown.</p> </sec> <sec id="pros22787-sec-0002" sec-type="section"> <title>METHODS</title> <p>Fluorescence in situ hybridization and immunohistochemistry were utilized to detect ERG rearrangement, SPINK1 expression, and EGFR aberrations in a cohort of 211 PCa patients with radical prostatectomy. Real‐time quantitative PCR and Western blotting were used to study the transcript and protein expression levels. Cellular distribution of E‐cadherin and vimentin were observed by immunofluorescence. Cellular function was evaluated by siRNA, transwell, and wound healing assay, respectively.</p> </sec> <sec id="pros22787-sec-0003" sec-type="section"> <title>RESULTS</title> <p>SPINK1‐induced Epithelial‐mesenchymal transition (EMT) in benign prostate RWPE cells, manifested by acquisition of mesenchymal morphology, alternation of EMT markers as well as migration and invasion capabilities. Knockdown of SPINK1 in 22RV1 PCa cells results in up‐regulation of E‐cadherin and down‐regulation of vimentin. SPINK1‐induced EMT is mediated by EGFR, in which MAPK/MEK/ERK pathway is mainly<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="pros22787-sec-0001" sec-type="section"> <title>BACKGROUND</title> <p>Overexpression of serine protease inhibitor Kazal type 1 (SPINK1) defines an aggressive molecular subtype of ETS fusion‐negative prostate cancer (PCa) patients in western countries. However, how SPINK1 contributes to PCa invasion and metastasis is largely unknown.</p> </sec> <sec id="pros22787-sec-0002" sec-type="section"> <title>METHODS</title> <p>Fluorescence in situ hybridization and immunohistochemistry were utilized to detect ERG rearrangement, SPINK1 expression, and EGFR aberrations in a cohort of 211 PCa patients with radical prostatectomy. Real‐time quantitative PCR and Western blotting were used to study the transcript and protein expression levels. Cellular distribution of E‐cadherin and vimentin were observed by immunofluorescence. Cellular function was evaluated by siRNA, transwell, and wound healing assay, respectively.</p> </sec> <sec id="pros22787-sec-0003" sec-type="section"> <title>RESULTS</title> <p>SPINK1‐induced Epithelial‐mesenchymal transition (EMT) in benign prostate RWPE cells, manifested by acquisition of mesenchymal morphology, alternation of EMT markers as well as migration and invasion capabilities. Knockdown of SPINK1 in 22RV1 PCa cells results in up‐regulation of E‐cadherin and down‐regulation of vimentin. SPINK1‐induced EMT is mediated by EGFR, in which MAPK/MEK/ERK pathway is mainly involved. Connective tissue growth factor (CTGF) might be an important down‐stream molecule of SPINK1–EGFR axis. Clinically, SPINK1 and EGFR were significantly co‐overexpressed in a cohort of Chinese PCa patients (n &gt; 200). SPINK1 is an unfavorable prognostic factor in Chinese PCas (<italic>P</italic> = 0.025).</p> </sec> <sec id="pros22787-sec-0004" sec-type="section"> <title>CONCLUSIONS</title> <p>These findings suggest that SPINK1 promotes EMT through EGFR signaling pathway in PCa and SPINK1 could be a new prognostic marker in Chinese PCas. <italic>Prostate 74:689–701, 2014</italic>. © 2014 Wiley Periodicals, Inc.</p> </sec> </abstract> … (more)
- Is Part Of:
- Prostate. Volume 74:Issue 7(2014)
- Journal:
- Prostate
- Issue:
- Volume 74:Issue 7(2014)
- Issue Display:
- Volume 74, Issue 7 (2014)
- Year:
- 2014
- Volume:
- 74
- Issue:
- 7
- Issue Sort Value:
- 2014-0074-0007-0000
- Page Start:
- 689
- Page End:
- 701
- Publication Date:
- 2014-03-12
- Subjects:
- Prostate -- Diseases -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0045 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/pros.22787 ↗
- Languages:
- English
- ISSNs:
- 0270-4137
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6935.194000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3089.xml